AI assistant
BIOVIE INC. — Director's Dealing 2025
Jan 7, 2025
35090_dirs_2025-01-07_b9fc2a67-8a25-41d6-aba7-778f6a27e9b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOVIE INC. (BIVI)
CIK: 0001580149
Period of Report: 2024-11-20
Reporting Person: BERMAN RICHARD J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-20 | Common Stock | A | 34200 | $0.00 | Acquired | 40643 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | Stock Option (right to buy) | $1.90 | A | 23155 | Acquired | 2029-12-20 | Common Stock (23155) | Direct |
Footnotes
F1: Represents a restricted stock unit ("RSU") grant, which was approved by the compensation committee of the issuer's board of directors, subject to board approval, which was obtained on November 20, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting.
F2: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026.